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Structural remodeling of resistance arteries
in uremic hypertension
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Structural remodeling of resistance arteries in uremic hyperten-
sion.
Background. Structural remodeling of the resistance vascu-
lature is present in many forms of human and experimental
hypertension. In particular, an increase in the ratio of wall thick-
ness to lumen diameter develops, and might in itself maintain
hypertension by increasing vascular resistance. Because ure-
mia is associated with raised peripheral resistance, hyperten-
sion, and histologic changes suggestive of vascular remodeling,
we sought to formally examine the structural and mechanical
(elastic) properties of isolated pressurized resistance arteries in
uremic hypertension.
Methods. Cremaster, cerebral and mesenteric arteries from
subtotally nephrectomised Wistar-Kyoto rats, normotensive
control Wistar-Kyoto rats, and spontaneously hypertensive rats
were mounted on a pressure myograph and relaxed in calcium-
free buffer. Wall thickness and lumen diameter were measured
at increasing lumen pressures from 10 to 200 mm Hg, and from
this wall:lumen ratio, wall cross-sectional area, and an index of
elasticity were derived.
Results. In uremic hypertensive animals increased wall:lumen
ratio and decreased lumen diameter was seen in cremaster and
mesenteric arteries, although no significant changes were ob-
served in cerebral arteries, compared to normotensive controls.
In spontaneously hypertensive animals increased wall thickness
and wall:lumen ratio was seen in cerebral and mesenteric ar-
teries, decreased lumen diameter in cremaster and mesenteric
arteries, and increased wall cross-sectional area in cerebral ar-
teries, compared to normotensive controls. Elasticity of the ar-
terial wall in uremic and spontaneously hypertensive animals
did not differ from normotensive controls.
Conclusion. Cremaster and mesenteric resistance arteries un-
dergo predominantly eutrophic inward remodeling in uremic
hypertension, broadly similar to that seen in spontaneous hy-
pertension.
Changes in the structural properties of resistance ves-
sels have been observed in various forms of human
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artery.
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[1–3] and experimental [4–6] hypertension. Struc-
tural (dimensional) changes manifest as alterations in
wall thickness and lumen diameter, and therefore in
wall:lumen ratio; remodeling is the term used to describe
this process. Eutrophic inward remodeling implies re-
organization of existing vascular wall material around
a reduced lumen, such that wall cross-sectional area is
not altered (no vascular growth); hypertrophic inward
remodeling indicates lumen reduction due to increased
wall cross-sectional area (vascular growth). These pro-
cesses are depicted schematically in Figure 1. In general,
hypertension is associated with either eutrophic or hyper-
trophic inward remodeling; eutrophic remodeling being
seen, for example, in essential hypertension [1, 7, 8], and
hypertrophic remodeling in renovascular hypertension
[9]. Both forms frequently coexist in different vascular
beds of the same individual, such as in the spontaneously
hypertensive rat [5, 10, 11].
Arterial diameter is affected by lumen pressure (or
more strictly the transmural pressure) and smooth mus-
cle activation. Comparisons of arterial structure are com-
monly performed at the standard pressure of 100 mm
Hg [5], with active smooth muscle tension abolished by
calcium-free buffer. Under such circumstances, an in-
crease in wall:lumen ratio could be due to structural
remodeling [12] or to decreased arterial elasticity [4].
Hence, before attributing changes in arterial dimensions
to structural remodeling it is necessary to exclude a dif-
ference in elasticity [1, 12]. It follows that full assessment
of vascular structure requires study under increasing de-
grees of distention in order to measure both structural
and elastic parameters, and visualization of isolated ar-
teries cannulated and pressurized on a myograph allows
such measurement.
If inward remodeling or decreased elasticity of an
artery is present, then the resistance to flow through that
artery will be increased since, according to the Poiseuille
equation, resistance is proportional to the fourth power
of diameter. This might be expected to manifest as raised
peripheral vascular resistance causing hypertension, and
as impaired vasodilator reserve limiting the response to
exercise or ischemia. Because uremia is associated with
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Fig. 1. Diagramatic representation of remodeling. (A) Normal artery,
with lumen diameter (D) and wall thickness (WT) labeled. (B) Hyper-
trophic inward remodeling has occurred; the wall cross-sectional area
(shaded) has increased and wall:lumen ratio is elevated, due to addition
of material to the inner surface of the arterial wall. (C) Eutrophic inward
remodeling has occurred; wall cross-sectional area is unchanged but the
wall:lumen ratio is increased, due to the re-organization of existing wall
material around a narrower lumen (not drawn to scale).
hypertension and raised vascular resistance [13], de-
creased forearm post-ischemic hyperemia [14], and his-
tologic evidence suggestive of vascular remodeling [15],
we sought to establish the structural and elastic proper-
ties of isolated pressurized resistance arteries in uremic
hypertension.
The subtotal nephrectomy model of uremic hyperten-
sion was employed using Wistar-Kyoto (WKY) rats, and
compared with nonuremic normotensive controls and
nonuremic spontaneously hypertensive animals. The pur-
pose of including nonuremic hypertensive animals (spon-
taneously hypertensive) in this study was to attempt to
control for the effect of hypertension in uremic animals
[16, 17], since vascular changes may occur in response
to either uremia or to hypertension or both. We studied
cremaster and mesenteric arteries because the skeletal
muscle and splanchnic circulations control a substantial
proportion of the peripheral resistance [18], and cerebral
arteries because hypertensive vascular end-organ dam-
age is prevalent in uremia [19].
METHODS
Animals
All procedures had the prior approval of the Home
Office (Project License number 70/5014), and were per-
formed in accordance with the Animals Scientific Pro-
cedures Act, 1986. Twelve to 14-week-old male WKY
and spontaneously hypertensive rats were obtained from
Harlan Ltd. (Bicester, Oxfordshire, UK). General anes-
thesia was induced for both stages of the subtotal
nephrectomy procedure. This was achieved by intramus-
cular injection of HypnormTM 1 mL/kg body weight
(comprising fentanyl citrate 0.315 mg/mL plus fluanisone
10 mg/mL) (Janssen-Cilag Ltd., Buckinghamshire, UK)
and intraperitoneal injection of diazepam 2.5 mg/kg (CP
Pharmaceuticals Ltd., Wrexham, UK). Postoperative
analgesia was provided by subcutaneous injection of
buprenorphine 50 lg/kg (Schering-Plough Ltd., Welwyn
Garden City, Hertfordshire, UK). Left subtotal nephrec-
tomy through a midline abdominal incision removed ap-
proximately three-fourths of that kidney, with total right
nephrectomy via a flank incision 1 week later. Control
WKY and spontaneously hypertensive animals under-
went sham surgery in which the appropriate kidney was
stripped of its capsule only. Animals were maintained
for an average 15 to 16 weeks during which time WKY
contol and spontaneously hypertensive rats were pair fed
with their uremic WKY partner. Then, under halothane
general anesthesia, an abdominal aortic catheter was
inserted retrogradely through the femoral artery, hep-
arinized, and exteriorized through the skin at the nape
of the neck [20]. Two to three days later, with the rat
was conscious and free to move in its cage, mean arte-
rial pressure was measured by attaching the catheter to
a pressure transducer (model number 60–3003) Harvard
Apparatus, Cambridge, MA, USA). Blood pressure was
recorded for at least 20 minutes until a stable value was
obtained. Blood was drawn for analysis, and the animal
killed by cervical dislocation. Cremaster muscle, brain,
and mesentery were placed in ice-cold physiologic salt
solution (PSS). The 1A branch of the cremaster [21], the
middle cerebral artery at its most lateral position over the
hemisphere, and the first order branch of the mesenteric
artery [22] were studied.
Drugs and solutions
PSS had the following composition (mmol/L): 119
NaCl, 4.7 KCl, 25 NaHCO3, 1.17 KH2PO4, 1.17 MgSO4,
2.0 CaCl2, and 5.5 glucose. Calcium-free PSS con-
tained ethyleneglycol–bis (b-aminoethylether)-N, N′-
tetraacetic acid (EGTA) 1 mmol/L and sodium nitroprus-
side 100 lmol/L.
Perfusion myograph
The myograph method has been described [4, 20].
Briefly, an artery was mounted between the two glass
microcannulas of a myograph (Living Systems Instru-
mentation, Burlington, VT, USA) and viewed through
a microscope. Calcium-free PSS was gassed (95% O2/5%
CO2) and heated in a reservoir, and circulated at a rate of
40 mL/min to the vessel chamber. Temperature was main-
tained at 33◦C for cremaster (its temperature in vivo)
and 37◦C for cerebral and mesenteric arteries. Active
smooth muscle tension was lost during equilibration in
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calcium-free PSS. Passive lumen diameter and wall thick-
ness were then measured at lumen pressures from 10 to
200 mm Hg using a video dimension analyser. Because the
vessel was immersed in less than 1 cm of PSS within the
chamber, lumen pressure was negligibly different from
transmural pressure. Measurements performed with this
myograph system are accurate to 1 lm. All measurements
were performed by the same investigator, and intraob-
server variation was <1 lm.
Calculations
The following calculations were used:
Creatinine clearance(mL/min) = UCr · V/PCr · t
where UCr is urinary creatinine and PCr is plasma cre-
atinine concentration (lmol/L), and V is the volume of
urine (mL) collected in time t (minutes).
Wall cross-sectional area (CSA)(lm2)
=1/4.p.{(D + 2.WT)2 − D2}
where D is lumen diameter (lm) and WT is wall thick-
ness (lm) at a given pressure. Wall:lumen ratio R (%) =
100.WT/D. Circumferential stress r (N/m2) = P.D/2.WT.
(P is converted to N/m2 by the factor 1 mm Hg = 133.4
N/m2). Circumferential strain e = (D – Do)/Do, where Do
is the “original” diameter at 10 mm Hg (it is difficult to
accurately determine internal diameter of resistance ar-
teries at pressures lower than this [23]). The data for each
individual artery can be fitted to a curve r = ro.eb·e us-
ing least-squares analysis, where ro is the circumferential
stress at 10 mm Hg, and b is a constant. Furthermore, the
elastic characteristic of an artery can be described by the
tangential elastic modulus of its wall material, E, where
E = dr/de [4]. It follows that dr/de = b .ro.eb·e = b .r.
The constant b therefore describes the linear slope of the
tangential elastic modulus versus stress, and is used as an
index of elasticity [4, 24]. The higher the value of b , the
lower the elasticity of the wall material.
Structural changes in small arteries are frequently due
to the dual processes of remodeling and growth (hy-
pertrophy) [3], although one process frequently domi-
nates. The relative contribution of each can be assessed
by inspection of the calculated “remodeling index” and
“growth index.” Here, remodeling index is defined as
the percentage of the observed difference in the internal
diameter of hypertensive (uremic or spontaneous) and
normotensive arteries that could be accounted for by re-
modeling of the normotensive vessel. If the remodeling
index is not equal to 100%, then there must have been
growth, and growth index is defined as the percent in-
crease in wall cross-sectional area of the hypertensive
(uremic or spontaneous) relative to normotensive arter-
ies. The remodeling and growth indices were calculated
by standard methods [3], which are not elaborated here,
when a statistically significant difference in one of the ar-
Table 1. General data
Uremic Wistar- Spontaneously
Wistar- Kyoto hypertensive
Animal Kyoto controls rats
data (N = 23) (N = 33) (N = 28)
Time of uremia/sham 15.1 (0.4) 15.2 (0.5) 15.1 (0.5)
uremia weeks
Mean arterial 166 (5)a,b 139 (2) 194 (3)b,c
pressure mmHg
Blood hemoglobin 7.9 (0.3)a,b 13.3 (0.3) 14.1 (0.4)
g/dL
Plasma creatinine 249 (25)a,b 45 (3) 47 (3)
lmol/L
Creatinine clearance 0.41 (0.09)a,b 2.98 (0.43) 2.61 (0.32)
mL/min
Weight g 303 (6)a,b 360 (3) 384 (5)
aP < 0.001 compared to Wistar-Kyoto controls; bP < 0.001 compared to spon-
taneously hypertensive rats; cP < 0.001 compared to uremic Wistar-Kyoto.
terial structural (dimensional) parameters was observed
between experimental groups.
Statistical analyses
Values are represented as mean (standard error). In
all comparisons, there were three separate groups; WKY
uremic rats, WKY controls, and spontaneously hyper-
tensive rats. Therefore one-way analysis of variance
(ANOVA) was chosen for comparison of means. The
Bonferroni correction was applied to allow comparisons
between each combination of two groups. The primary
comparisons were between uremic WKY and WKY con-
trols, and between spontaneously hypertensive rats and
WKY controls, although, when appropriate, reference is
made to comparison between uremic WKY and sponta-
neously hypertensive rats. Although comparisons were
made at the standard lumen pressure of 100 mm Hg [5],
the data for diameter and wall thickness are also plotted
across the full pressure range to demonstrate the consis-
tency of the changes. In all analyses the significance level
was taken as P < 0.05.
RESULTS
General animal data
Animal groups had very similar periods of ure-
mia/sham uremia (Table 1). Mean arterial pressure was
raised in both uremic WKY and spontaneously hyperten-
sive rats compared to WKY controls, and spontaneously
hypertensive rat pressure was also significantly higher
than uremic WKY. Uremic WKY animals were anemic,
with substantially raised plasma creatinine, decreased
creatinine clearance, and lower body mass compared
to both WKY controls and spontaneously hypertensive
rats.
Cremaster arteries
Cremaster arteries from uremic WKY demonstrated
significantly decreased lumen diameter and increased
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Table 2. Characteristics of branch 1A cremaster arteries at 100 mm
Hg lumen pressure
Uremic Wistar- Spontaneously
Wistar- Kyoto hypertensive
Cremaster Kyoto controls rats
artery (N = 19) (N = 20) (N = 14)
Wall thickness lm 15.4 (1.9) 11.1 (0.9) 13.4 (1.2)
Lumen diameter lm 149 (3)a 168 (3) 151 (5)b
Wall to lumen ratio % 10.6 (1.4)c 6.6 (0.5) 9.0 (0.9)
Wall cross-sectional 8020 (1064) 6260 (552) 6926 (739)
area lm2
b value 8.2 (0.6) 6.7 (0.6) 5.7 (0.4)
Remodeling index % 62 — 85
Growth index % 28 — 11
aP < 0.005 compared to Wistar-Kyoto controls; bP < 0.01 compared to Wistar-
Kyoto controls; cP < 0.02 compared to Wistar-Kyoto controls.
wall:lumen ratio, with no significant difference in wall
cross-sectional area compared to WKY controls (Table 2)
(Figs. 2 and 3). The remodeling index was 62% whereas
the growth index was 28%. The elasticity (b value) for
uremic WKY was not significantly different to WKY
controls. Arteries from spontaneously hypertensive rats
showed reduced lumen diameter, with no significant dif-
ference in wall cross-sectional area compared to WKY
controls. The remodeling index was 85% and the growth
index 11%. The elasticity (b value) for spontaneously hy-
pertensive rats was not significantly different to WKY
controls. These data confirm that the changes in ure-
mic WKY and spontaneously hypertensive rat cremas-
ter arteries are predominantly due to eutrophic inward
remodeling.
Cerebral arteries
Cerebral arteries from uremic WKY showed no sig-
nificant structural changes compared to WKY controls
(Table 3) (Figs. 2 and 3). The elasticity (b value) for ure-
mic WKY did not differ from WKY controls. Arteries
from spontaneously hypertensive rats showed increase in
wall thickness, wall:lumen ratio, and wall cross-sectional
area compared to WKY controls. The growth index was
46% and the remodeling index −3%. The elasticity (b
value) for spontaneously hypertensive rats was not sig-
nificantly different to WKY controls. These data confirm
that uremic WKY cerebral arteries undergo no signifi-
cant remodeling, while spontaneously hypertensive rat
cerebral arteries display hypertrophic remodeling.
Mesenteric arteries
Mesenteric arteries from uremic WKY demonstrated
significantly decreased lumen diameter and increased
wall:lumen ratio compared to WKY controls (Table 4)
(Figs. 2 and 3). Wall cross-sectional area was not signifi-
cantly different in uremic WKY compared to WKY con-
trols. The remodeling index was 95% compared to the
growth index of 11%. The elasticity (b value) for uremic
WKY was not significantly different to WKY controls.
Arteries from spontaneously hypertensive rats showed
increase in wall thickness, reduced lumen diameter, and
increased wall:lumen ratio compared to WKY controls.
Wall cross-sectional area was not significantly increased
in spontaneously hypertensive rats compared to WKY
controls. The remodeling index was 84% while the growth
index was 23%. The elasticity (b value) for spontaneously
hypertensive rats was not significantly different to WKY
controls. These data confirm that uremic WKY and spon-
taneously hypertensive mesenteric arteries undergo pre-
dominantly eutrophic inward remodeling.
DISCUSSION
The important finding of this study is that cremas-
ter and mesenteric arteries from uremic hypertensive
rats display predominantly eutrophic inward remodel-
ing with no change in elasticity, when compared to ves-
sels from normotensive control animals. No significant
changes were seen in cerebral arteries from uremic hy-
pertensive animals.
In a classic autopsy study [25], renal small arteries from
patients with Bright’s (chronic renal) disease were shown
to have increased wall thickness relative to lumen. This
finding was later extended to other vascular beds [26].
These observations could not, however, distinguish be-
tween structural change and greater vascular contraction
by arteries from uremic subjects during the fixation pro-
cess. Recent thorough histologic studies using procaine to
relax vascular smooth muscle prior to fixation at a con-
trolled lumen pressure show that myocardial arterioles in
uremia display wall thickening and increased wall:lumen
ratio [15]. Histologic assessment, however, cannot distin-
guish between remodeling and change in arterial elas-
ticity. To our knowledge, this paper provides the first
systematic assessment of the structural and elastic prop-
erties of isolated pressurized resistance arteries in uremic
hypertension; the findings support previous histological
studies, and confirm that the basis is predominantly struc-
tural remodeling rather than change in elasticity.
Several factors might cause structural cardiovascular
changes in uremia. These include uremic hyperparathy-
roidism [27], abnormal activity of the renin-angiotensin
system [15], and accumulation of endothelin [28]. How-
ever, increased wall:lumen ratio is a common finding in
many forms of hypertension [2] and it is conceivable
that structural (dimensional) changes are simply a con-
sequence of raised arterial pressure [29]. The structural
changes reported here in uremic hypertensive cremas-
ter and mesenteric arteries were comparable in degree
to those from spontaneously hypertensive animals even
though the magnitude, and probably also the duration
[30], of hypertension were substantially higher in the
latter. Since there is histologic evidence of myocardial
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Fig. 2. Artery passive internal diameter plot-
ted against lumen pressure. Uremic Wistar-
Kyoto (WKY) (), WKY control (), and
spontaneously hypertensive rats (). At 100
mm Hg lumen pressure, cremaster arter-
ies from both uremic WKY and spon-
taneously hypertensive rats demonstrated
significantly decreased lumen diameter com-
pared to WKY controls (P < 0.005 and P
< 0.01, respectively). Cerebral arteries from
neither uremic WKY nor spontaneously hy-
pertensive rats showed significant change in
lumen diameter compared to WKY controls.
Mesenteric arteries from both uremic WKY
and spontaneously hypertensive rats demon-
strated significantly decreased lumen diame-
ter compared to WKY controls (P < 0.005 and
P < 0.02, respectively).
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Fig. 3. Wall thickness plotted against lumen
pressure. Uremic Wistar-Kyoto (WKY) (),
WKY controls (), and spontaneously hy-
pertensive rats (). At 100 mm Hg lumen
pressure, cremaster arteries from neither ure-
mic WKY nor spontaneously hypertensive
rats showed significant increase in wall thick-
ness compared to WKY controls. Cerebral ar-
teries from spontaneously hypertensive rats
but not uremic WKY showed an increase in
wall thickness compared to WKY controls
(P < 0.001 for spontaneously hypertensive
rats). Mesenteric arteries from spontaneously
hypertensive rats but not uremic WKY
demonstrated a significant increase in wall
thickness compared to WKY controls (P <
0.01 for spontaneously hypertensive rats).
arteriolar wall thickening in uremia even in the absence
of hypertension [27], it is possible to contemplate that
uremia and hypertension act synergistically to effect vas-
cular changes. Alternatively, because in uremia the dis-
tensibility of large (conduit) arteries is decreased [31], it
is possible that the distal arteries are exposed to a greater
proportion of the pulse pressure that speculatively might
enhance the small artery structural changes.
A likely functional consequence of arterial remodeling
reported here in uremic hypertension is raised peripheral
resistance, because geometrical reasoning dictates that a
smaller lumen diameter would follow from any given de-
gree of smooth muscle shortening [32]. The result would
be increased vascular resistance, which is known to be
present in uremic [13] and essential [33] hypertension. Al-
though the matter is debated [34, 35], this so-called “am-
plifier hypothesis” provides a possible means by which
vascular resistance is increased without requiring any in-
crease in vascular smooth muscle tension generation. It
is therefore an attractive hypothesis, since most studies
find normal vascular contractility in many types of hyper-
tension [24]. Additionally, inward remodeling would also
be expected to limit the maximum attainable arterial di-
ameter [29]. This may explain why postischemic forearm
blood flow is decreased in uremia [14] and in essential
hypertension [36], and why cardiac ischemia may occur
in the absence of discrete coronary stenosis in uremic
[37] as well as nonuremic hypertension [38]. Nevertheless,
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Fig. 4. Wall stress plotted against lumen
pressure. Uremic Wistar-Kyoto (WKY) (),
control WKY (), and spontaneously hyper-
tensive rats ().
Table 3. Characteristics of middle cerebral arteries at 100 mm Hg
lumen pressure
Uremic Wistar- Spontaneously
Wistar- Kyoto hypertensive
Cerebral Kyoto controls rats
artery (N = 17) (N = 16) (N = 14)
Wall thickness lm 11.6 (0.7) 10.2 (0.5) 15.0 (1.1)a
Lumen diameter lm 234 (5) 241 (7) 232 (6)
Wall to lumen ratio % 4.98 (0.31) 4.24 (0.18) 6.44 (0.41)a
Wall cross-sectional area lm2 8896 (588) 8161 (544) 11884 (1094)b
b value 12.0 (0.7) 9.9 (0.5) 9.5 (0.6)
Remodeling indexc % NA NA −3
Growth indexc % NA NA 46
NA, not applicable.
aP < 0.001 compared to Wistar-Kyoto controls; bP < 0.005 compared to Wistar-
Kyoto controls; cRemodeling index and growth index not calculated as no signifi-
cant structural (dimensional) differences were present compared to Wistar-Kyoto
controls.
factors other than remodeling, such as microvascular rar-
efaction [39, 40], might also cause or contribute to the ob-
served hemodynamic changes. Finally, the changes seen
in both uremic and spontaneous hypertension serve to
decrease the passive wall stress of arteries at any given
lumen pressure or, when blood pressure is high, they
tend to normalize wall stress. The relation of pressure
to wall stress (which is itself derived from the parame-
ters pressure, diameter, and wall thickness) for arteries
in each group is shown by Figure 4. This might repre-
sent an adaptation to preserve microvascular integrity
under conditions of raised arterial pressure. In this re-
spect the absence of significant remodeling of the cerebral
artery in uremic hypertension, together with impairment
in contractile response to lumen distension [41, 42], may
contribute to the association of uremia with hemorrhagic
stroke in humans [19] and animals [42].
We report that spontaneously hypertensive cremaster
and mesenteric arteries undergo eutrophic inward re-
Table 4. Characteristics of first order mesenteric arteries at 100 mm
Hg lumen pressure
Uremic Wistar- Spontaneously
Wistar- Kyoto hypertensive
Mesenteric Kyoto controls rats
artery (N = 8) (N = 12) (N = 12)
Wall thickness lm 20.7 (2.0) 15.9 (0.9) 22.2 (1.4)a
Lumen diameter lm 342 (12)b 411 (16) 359 (9)c
Wall to lumen ratio % 6.0 (0.4)d 3.9 (0.2) 6.2 (0.4)e
Wall cross-sectional 24034 (3138) 21640 (1810) 26600 (1899)
area lm2
b value 6.1 (0.6) 5.2 (0.4) 5.8 (0.3)
Remodeling index % 95 — 84
Growth index % 11 — 23
aP < 0.01 compared to Wistar-Kyoto controls; bP < 0.005 compared to
Wistar-Kyoto controls; cP < 0.02 compared to Wistar-Kyoto controls; dP =
0.001 compared to Wistar-Kyoto controls; eP < 0.001 compared to Wistar-Kyoto
controls.
modeling consistent with previous studies [10, 43, 44]. We
demonstrated that spontaneously hypertensive cerebral
vessels display hypertrophic remodeling, also conforming
with earlier reports [5, 11]. Cerebral artery hypertrophy
appears principally to be a response to elevated blood
pressure [6, 45, 46], and other models of hypertension
in which blood pressure is not raised to the same extent
as in the spontaneously hypertensive rats do not display
cerebral hypertrophy [4, 47]. This might explain why we
found no hypertrophy of uremic WKY cerebral arteries.
Small arteries in vivo have smooth muscle tone which
is modified by the metabolic demands of the tissue they
supply [24]. In anemia for example, arteries may dilate in
response to tissue hypoxia [48], with blood flow through
them increasing as a consequence of both vasodilation
and lowered blood viscosity. Because chronic elevation
of blood flow through a small artery results in outward
hypertrophic remodeling [49], it is possible that chronic
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anemia in the uremic hypertensive group affected the
remodeling process.
CONCLUSION
We have shown that cremaster and mesenteric re-
sistance arteries of uremic hypertensive rats manifest
inward remodeling without vascular hypertrophy and
without change in elasticity. Such remodeling might con-
tribute to the maintenance of raised vascular resistance,
and decrease blood flow reserve, in uremic hypertension.
Reprint requests to David New, Department of Renal Medicine, Hope
Hospital, Salford, Manchester M6 8HD, United Kingdom.
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